Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Singapore Pte. Ltd.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
A patient for whom the physician has decided to initiate treatment with a Luteinizing Hormone Releasing Hormone (LHRH) agonist in standard clinical practice
Biopsy-proven prostate adenocarcinoma
Locally advanced prostate cancer with biochemical relapse radical prostatectomy and/or radiotherapy, OR hormonal treatment-naive advanced or metastatic prostate cancer patient who has not received chemotherapy and has no plans to undergo treatment with chemotherapy at study entry.
Patient who indicates that once the study is completed, he expects having access to androgen deprivation therapy (ADT), either medical or surgical, within the local healthcare system (either through public/ private health insurance or out of pocket payment).
You may not be if
Patient with castrate resistant prostate cancer
Patient who previously underwent bilateral orchiectomy
Patient who has received prior treatment with LHRH analogues
Prior or concomitant treatment with systemic chemotherapy. A patient where there is a likelihood to receive systemic chemotherapy should not be enrolled
Life expectancy of \< 1 year due to comorbidities
Participation in another interventional clinical trial within one month prior to study entry or during the duration of the study
Patient who plans to receive intermittent ADT at the time of study entry
Patient receiving non-palliative radiotherapy within 3 months prior to study entry
Patient receiving adjuvant ADT in combination with definitive radiotherapy
Patient with metastatic hormonal treatment-naive prostate cancer, for whom chemo-hormonal treatment (combination of Docetaxel and ADT) is indicated.
Patient with hypersensitivity to gonadotropin releasing hormone (GnRH), GnRH agonist analogs or any of the components of ELIGARD®
Patient with any contraindication for ELIGARD® use based on local prescribing information
